SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
16-Nov-21 3:09 PM View: | Sab Biotherapeutics, Inc. (SABS) | 26-Oct-21 | Market Sale | 278 | $7.90 | $2,196.20 | (10%) 2.77K to 2.49K | (20%) |
16-Nov-21 3:09 PM View: | Sab Biotherapeutics, Inc. (SABS) | 25-Oct-21 | Grant | 129 | $7.78 | $1,003.62 | 5% 2.64K to 2.77K | 22% |
16-Nov-21 3:09 PM View: | Sab Biotherapeutics, Inc. (SABS) | 18-Oct-21 | Grant | 2,475 | $10.10 | $24,997.50 | 1509% 0.16K to 2.64K | (6%) |
16-Nov-21 3:09 PM View: | Sab Biotherapeutics, Inc. (SABS) | 29-Sep-21 | Grant | 10 | $10.08 | $100.80 | 6% 0.15K to 0.16K | (6%) |
16-Nov-21 3:09 PM View: | Sab Biotherapeutics, Inc. (SABS) | 28-Sep-21 | Grant | 154 | $10.08 | $1,552.27 | 100% 0 to 0.15K | (6%) |